Carole Huntsman insider trades

Open-market stock purchases and sales by Carole Huntsman, Chief Commercial Officer at Madrigal Pharmaceuticals, Inc, from SEC Form 4 filings since Nov 20, 2023.

Recent trades

DateStockTradeValue
Mar 6, 2026MDGL Madrigal Pharmaceuticals, IncSold$181K
Mar 4, 2026MDGL Madrigal Pharmaceuticals, IncBought (not open market)—
Mar 4, 2026MDGL Madrigal Pharmaceuticals, IncBought (not open market)—
Jan 26, 2026MDGL Madrigal Pharmaceuticals, IncSold$282K
Jan 26, 2026MDGL Madrigal Pharmaceuticals, IncSold$167K
Nov 21, 2025MDGL Madrigal Pharmaceuticals, IncSold$22.5K
Nov 21, 2025MDGL Madrigal Pharmaceuticals, IncSold$45.2K
Nov 21, 2025MDGL Madrigal Pharmaceuticals, IncSold$493K
Nov 21, 2025MDGL Madrigal Pharmaceuticals, IncSold$78.8K
Nov 21, 2025MDGL Madrigal Pharmaceuticals, IncSold$66.7K
Nov 21, 2025MDGL Madrigal Pharmaceuticals, IncSold$112K

Companies traded

  • MDGL Madrigal Pharmaceuticals, Inc: 16 sales, last Mar 6, 2026

Get free alerts when Carole Huntsman files a new trade →